Logo Image
News
Videos
Podcasts
Conferences
Conference CoverageConference Listings
More
Clinical Forum Insights

Subscribe

  • News
  • Videos
  • Podcasts
  • Conferences
  • Clinical Forum Insights
  • Subscribe
  • Fibromyalgia
  • Gout
  • Lupus
    • Lupus Nephritis
    • Cutaneous Lupus Erythematosus
    • Systemic Lupus Erythematosus
  • Osteoarthritis
  • Osteoporosis
  • Psoriatic Arthritis
  • Rheumatoid Arthritis
  • Sjögren's Disease
  • Spondyloarthritis
    • Axial spondyloarthritis
    • Nonradiographic axial spondyloarthritis
Spotlight -
FDA News
Advertisement

Dmitry M. Arbuck, MD

Advertisement

Articles by Dmitry M. Arbuck, MD

Fibromyalgia Classification, Triggers, and Etiology

ByDmitry M. Arbuck, MD
May 23rd 2012

Our evolving understanding of the potential causes of fibromyalgia, and its placement along a continuum of related conditions, informs an individualized treatment approach.

Advertisement

Latest Updated Articles

  • Fibromyalgia Classification, Triggers, and Etiology
    Fibromyalgia Classification, Triggers, and Etiology

    May 23rd 2012



Advertisement
Advertisement

Trending on Rheumatology Live

1

Bimekizumab Beats Risankizumab on ACR50 in First IL-17A/F vs IL-23 Head-to-Head

2

TOGETHER-PsA:Tirzepatide + Ixekizumab Rapidly Improves PsA Disease Control With Obesity/Overweight

3

Early Joint Clearance With Bimekizumab Leads to Durable Disease Control in PsA

4

Autoantibody and IFN Burden Correlate With Nipocalimab Response in Sjögren's Disease

5

OLINGUITO: Filgotinib Meets Phase 3 Primary Endpoint in r/nr-axSpA, With Xenofon Baraliakos, MD, PhD

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
Rheumatology Live
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
News
Contact Us